Related Experiment Video
Updated: Jun 13, 2026
08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study
Hyo Song Kim1, Eun Kyoung Kim, Hyun Jung Jun
1Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Korea.
BMC Cancer
|April 30, 2010
Summary
This study reveals that noncutaneous melanoma prognosis varies by primary site. Differentiated treatment strategies are crucial for improving survival outcomes in these rare melanoma cases.
Area of Science:
- Oncology
- Dermatology
- Surgical Pathology
Background:
- Noncutaneous melanomas are rare cancers requiring characterization.
- Understanding clinical features and prognostic factors is essential for patient management.
- Previous studies have not sufficiently defined outcomes for diverse noncutaneous melanoma sites.
Purpose of the Study:
- To define the clinical characteristics of noncutaneous melanomas.
- To identify prognostic factors for patients undergoing curative resection.
- To compare survival outcomes between ocular and mucosal melanomas.
Main Methods:
- A multicenter study was conducted across four Korean institutions.
- Data from 141 patients diagnosed between June 1992 and May 2005 were analyzed.
- 129 patients met the selection criteria for analysis.
Main Results:
- Mucosal melanoma was more common (115 patients) than ocular melanoma (14 patients).
- Anorectum was the most frequent site for mucosal melanoma (30.2%).
- Curatively resected mucosal melanoma patients over 50 with incomplete resection had poorer survival; ocular melanoma showed better outcomes.
Conclusions:
- Prognosis for noncutaneous melanoma is site-dependent.
- Ocular melanoma generally has a better prognosis than mucosal melanoma.
- Tailored treatment approaches based on primary tumor site are necessary to improve survival.
